Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
SONIC FOUNDR SOFO
4.40%
SUPPORTCOM I SPRT
3.75%
UNISYS CORP UIS
3.31%
SHORETEL INC SHOR
3.22%
GREEN MOUNTA GMCR
3.13%
 

TODAY'S TOPICS

1. ZACKS EQUITY RESEARCH: We saw the first real glimpse into the impact of Medicare Part D this quarter since its introduction in January. Read the Analyst Interview article and get our Bull and Bear Stocks of the Day.

2. PROFIT TRACKS – PEG RATIO: Use two of the most powerful indicators in your investment philosophy.

3. ZACKS RANK BUY STOCKS: Today we highlight four new Zacks #1 Rank Stocks: Corrections Corporation of America (CXW), Sunoco, Inc. (SUN), OMI Corporation (OMM) and CryptoLogic, Inc. (CRYP). Get these stories below.

4. FEATURED EXPERTS: Kevin Kennedy recaps the Nasdaq’s performance over the past eight years. Learn what he discovered and check out a stock.

- - - - - - - - - - - - - - - - - - - - -

Are you getting a return of 48% per year?

At an annual rate of 48%, $10,000 will become $25.5 million in 20 years for your retirement. We've found one newsletter that has produced an annual return of 48.8% in its first two years. Fully documented. Why not get a return like that for yourself? A free 30-day trial is offered: Click Here.
 

Friday - August 11, 2006

Want to view the archive of past issues? Go to: http://at.zacks.com/?id=2283.

Manage Profit from the Pros subscription:
* Free Subscription: http://at.zacks.com/?id=2284
* Change of address: http://at.zacks.com/?id=2285
* Unsubscribe: http://at.zacks.com/?id=2286
 

1. ZACKS EQUITY RESEARCH

Back to top

As second quarter earnings season heads into its remaining days and weeks, we were interested in finding out how healthcare companies had been coping with the incorporation of Medicare Part D issues. This being the first quarter where results of the program show up in earnings reports, we spoke with senior analyst Chris Kallos to learn what some of the effects have been.

So far this earnings season, how are things progressing for healthcare stocks?

Earnings numbers overall have been generally healthy so far, with the possible exception of Aetna (AET), which reported a higher-than-expected medical loss ratio and disappointing enrollment growth, easing concerns of increasing competitive pricing.

More. . .

 
GOOD NEWS…The Zacks Quantitative Strategy Has Outperformed the S&P 500 for 11 Consecutive Quarters.

You can now benefit from this strategy by requesting your FREE Investment Kit.

Inside we will describe how you can invest in ALL the Zacks #1 Rank Stocks. Since 2002, this portfolio has outperformed the S&P 500 by a staggering 45%! Ben Zacks utilizes this strategy along with others to manage assets for his Private Clients. We would like to offer you this FREE KIT showing Ben's complete track record along with details on this time tested philosophy.

Get Your FREE ZACKS INVESTMENT KIT.
 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
Zacks Equity Research continued...

However, more importantly this quarter, we saw the first real glimpse into the impact of Medicare Part D since its introduction in January. That said, Humana (HUM) reported a sequential increase of 1.5 million stand-alone PDP members, up 77%, primarily driven by strong sales during the final two weeks of the open enrollment period. Notwithstanding the increase in MLR associated with Humana’s aggressive targeting of Medicare Part D beneficiaries, we believe the company has gained an important stake in this emerging segment and an opportunity to cross-sell higher margin products longer term.

Are investors still keeping the less-volatile healthcare stocks buoyant in this time of market uncertainty?

Fears of accelerating medical costs, which underpinned volatility in the sector following the first quarter, appear to have subsided. For the most part, managed care stocks remain less volatile given the strong industry fundamentals and government’s continued support of third-party participation in Medicare. Nonetheless, investors remain sensitive to any signs of weakness amongst the commercial MCOs without significant exposure to Medicare Part D.

Some of your sectors look better from a long-term perspective. What are some of your growth projections for things like managed care and medical services over the next year or two? Despite several common themes, the healthcare sector is non-homogenous and largely defined by differing levels of public and private participation and government subsidization, with the managed care sector a major case in point. With regard to managed care in particular, we believe the shift towards private provider participation in the areas of Medicare and Medicaid will continue to drive both earnings and sentiment over the medium term.

Notwithstanding unexpected inflationary pressure and further industry consolidation amongst MCOs, we anticipate earnings growth in the mid-teens over the next two years. Medical services also stand to benefit from the aging of the population and are similarly exposed to government health policy through reimbursement risk. Niche medical service providers such as NovaMed (NOVA) remain at the high end of the spectrum, with expected growth projections in the high teens driven by economies of scale and less exposure to uninsured groups.

To read the complete Analysts Interview, click here.

Chris Kallos is a senior analyst covering the healthcare and managed care sectors for Zacks Equity Research.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
MORE FROM ZACKS EQUITY RESEARCH...
 

Analyst Blog

Real-time market insights from Zacks Equity Research Analysts. Stocks featured recently include China Mobile (CHL), ACADIA Pharmaceuticals (ACAD), Consolidated Graphics (CGX) and AmBev (ABV). To see their latest posts, click here.

 
BULL OF THE DAY

Xilinx, Inc. (XLNX) - Attractive Entry Point. For full Zacks research report, click here.

 
BEAR OF THE DAY

U.S. Cellular (USM) - Risk & Uncertainty. For full Zacks research report, click here.

 
ZACKS INDUSTRY RANK

The Week of August 7

Strong reports from economically-sensitive industry groups provide proof the economy is continuing to grow. More...

 
EARNINGS TRENDS

Earnings Data: No Recession Soon

With double-digit earnings growth expected to continue, it is unlikely that we are about to go into a recession. More...

 
Rating Upgrades - NEW! 

Find out which stocks have been recently upgraded by Zacks Equity Research: click here.

 
Zacks Equity Research Buys - NEW! 

Read the reports on all of the stocks on the Zacks Equity Research Buy List: click here.

 
Learn More about Zacks Equity Research at http://at.zacks.com/?id=2287.

Full access to Zacks Equity Research reports is now available on Zacks.com :
http://at.zacks.com/?id=3009

Zacks Wealth Management: Own all the Zacks #1 Ranked stocks in a portfolio managed by Zacks. Learn more at http://at.zacks.com/?id=2696.
 


2. PROFIT TRACKS

Back to top

Zacks.com is proud to share with you some of the best trading strategies that truly allow you to Profit from the Pros. Today we highlight...
 

Profit Tracks: Upgrades and Revisions

This strategy focuses primarily on Positive EPS Estimate Revisions and Brokerage Rating Upgrades. Over the last 20 years Zacks Investment Research has proven that "earnings estimate revisions are the most powerful force driving stock prices." Studies have also shown that stocks receiving upward EPS revisions tend to receive additional upward revisions in the future. Then consider that stocks receiving these upward revisions generally have brokers upgrading their Ratings, which is also a proven mover of stock prices. There are other parameters to this strategy, but the Rating Upgrades and positive EPS Revisions are the two powerful active ingredients.

This screen focuses on EPS Revisions, along with Broker Ratings and Rating Changes. According to Zacks Investment Research "earnings estimate revisions are the most powerful force impacting stock prices". Couple that with the proven benefits of upgrades in ratings from brokerage firms and you have a strategy that delivered a +27% return in 2005.

Here are four stocks that make the grade for the PEG Ratio Profit Track:

Aleris International, Inc. (ARS), a Zacks #1 Rank (Strong Buy) company, recently announced that second-quarter adjusted earnings per share was a record $1.40. The result compares to last year’s 96 cents and tops the consensus estimate by almost 13%. Aleris International delivered earnings per share growth of 115% over the past five years. Continue your research on ARS at: http://at.zacks.com/?id=2290.

Epicor Software Corp. (EPIC) recently released its second-quarter report, stating that the results exceeded its expectations for total revenue, non-GAAP EPS and cash flow from operations. The company also noted that it is increasing its full year 2006 consolidated revenue guidance and its non-GAAP EPS guidance. Total revenues for the second quarter increased 40.2% to a record $99.5 million, versus the previous year’s $71.0 million. Quarterly earnings per share were about 21% ahead of the consensus estimate. EPIC has seen earnings per share growth of 78% over the past five years. Continue your research on EPIC at: http://at.zacks.com/?id=2291.

Helix Energy Solutions Group, Inc. (HLX), another Zacks #1 Rank (Strong Buy) name, has experienced earnings per share growth of 60% over the past five years. The company recently posted second-quarter earnings of 83 cents per share, surpassing analysts’ expectations by nearly 14% and outperforming the year-prior quarter. HLX commented that it had a record quarter on the back of continuing improvement in the market place for its contracting services. The company also reiterated that it expects 2006 earnings to fall in the higher range of $3.20 - $3.70 per share. Wall Street is forecasting $3.41, up 10 cents from one week ago. Continue your research on HLX at: http://at.zacks.com/?id=2292.

IPSCO Inc. (IPS), also a Zacks #1 Rank (Strong Buy) company, satisfies the criteria for this Profit Track as evidenced by its earnings per share growth of 338% over the past five years. In late July, the company reported second-quarter earnings of $3.25 per share, which beat the consensus estimate by approximately 18% and outpaced the year-prior total. Sales were a second quarter record $893.6 million, and represented a 29.9% year-over-year increase. Continue your research on IPS at: http://at.zacks.com/?id=2293.

To see the full list of stocks that currently pass this winning screen, go to http://at.zacks.com/?id=2294.

All the Profit Track strategies were created and backtested using the Research Wizard software from Zacks Investment Research. If you like this screening strategy, but want to narrow down the list of stocks and even improve the performance, then you should start a free trial to this powerful stock picking tool. Learn more about the Research Wizard free trial offer and our new special report “Top 10 Stock Screening Strategies” at: http://at.zacks.com/?id=2295.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 
SCREEN OF THE WEEK

Cheap Stocks and Big Returns

Kevin Matras goes over a screening strategy for finding cheap stocks with big returns: http://at.zacks.com/?id=2289.
 


3. ZACKS RANK BUY STOCKS

Back to top

Every day on Zacks.com we highlight four Zacks Rank Buy stocks. Each individual stock is chosen based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Momentum, Growth & Income and Value.
 

Aggressive Growth – Corrections Corporation of America (CXW)

Corrections Corporation of America (CXW) has exceeded earnings estimates for four consecutive quarters. All four analysts raised their estimates for this year. Over the past week, this year's estimates have increased 5.7% to $2.40 per share, while next year's numbers have also jumped 5.7%. The stock is trading at 22.1x next year's estimates, slightly above the projected long-term growth rate of 20%, giving the stock a PEG ratio of 1.10. Read the full analysis on CXW at: http://at.zacks.com/?id=2505.

 
Growth & Income – Sunoco, Inc. (SUN)

Sunoco, Inc. (SUN), a Zacks #1 Rank stock, topped the Street’s earnings expectations in seven out of the past nine quarters by an average margin of 19.8%. Consensus estimates are on the rise for this quarter and the full year of 2006. The Board of Directors recently approved a quarterly dividend of 25 cents per share and a $500 million increase to its share repurchase program. SUN has a return on equity of 57%, compared to 32% for the industry average. Read the full analysis on SUN at: http://at.zacks.com/?id=2506.

More...

 
Great Alternative Investment: Costa Rica Real Estate

Introducing Costa Esterillos, a private, gated community on the Central Pacific Coast of Costa Rica. For a very limited time, pre-development pricing is being offered on all over-sized home sites. All lots have spectacular ocean, river and mountain views. Build your own dream home or simply hold the land for the enormous appreciation potential! Register now to receive a complimentary information package and DVD.

http://at.zacks.com/?id=3088.
 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
Zacks Rank continued...

Momentum – OMI Corporation (OMM)

It’s been eleven trading sessions sinceOMI Corporation (OMM) delivered its Jun 2006 results, and the stock is still going strong. On Jul 25, the company reported earnings of 78 cents versus 55 cents last year, a 20% positive surprise over the consensus estimate. Sales grew 28.2% to $183.3 million and income grew 35.7% to $53.73 million. With the Jun 2006 results, it’s now been eight straight quarters since OMM disappointed. Read the full analysis on OMM at: http://at.zacks.com/?id=2507.

 
Value - CryptoLogic, Inc. (CRYP)

CryptoLogic, Inc. (CRYP), a Zacks #1 Rank stock, beat the Street’s earnings estimate in the past five quarters by an average margin of 15.4%. Earnings per share are expected to grow 20.0% over the next 3-5 years. Consensus estimates for this year and next are trending higher. The company is currently yielding 2.2% and has a return on equity of 31%, compared to 3% for the industry average. Read the full analysis on CRYP at: http://at.zacks.com/?id=2508.

 
Zacks Rank Resources


4. FEATURED EXPERTS

Back to top

Here we cast the spotlight on timely Featured Expert commentaries that recently appeared on Zacks.com.

 
Nasdaq Goes Nowhere Fast

Kevin Kennedy recaps Nasdaq’s performance over the past eight years. Learn what he discovered and check out a stock. http://at.zacks.com/?id=3089.

 
June-quarter Earnings Leaders

Richard Moroney looks at small-cap stocks that delivered impressive results. Read his analysis and check out some of his Buy List holdings. http://at.zacks.com/?id=2366.

 
After the Fed

Walter Frank sees the economy moving below its speed limit into next year. Learn what that means and discover a mutual fund. http://at.zacks.com/?id=2463.


OTHER TOOLS FROM ZACKS

Back to top

At the heart of Zacks Investment Research is the Zacks Rank investment philosophy that continues to vastly outperform the market. Our Zacks #1 Ranked (Strong Buys) have produced the following results for investors:

  • +32.4% average annual return since 1988 versus +11.9% for S&P 500
  • Outperformed S&P 500 in 16 of the last 17 years
  • +43.8% total return from 2000 to 2002 - the worst bear market in over 60 years.
  • +18% in 2005

And just as importantly, the Zacks #5 Rank stocks (Strong Sell) List has alerted investors as to which stocks to dump from Their portfolios to avoid unnecessary losses.

To truly take advantage of the Zacks Rank, you need to first understand how it works. That's why we created the free special report: "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions". Download a free copy now to prosper in the years to come, by visiting: http://at.zacks.com/?id=2296.

Or view the full list of Zacks #1 Ranked stocks at: http://at.zacks.com/?id=2297.

FREE PORTFOLIO TRACKER

Do you believe that these events affect stock prices?

  • Broker Recommendation changes
  • Earning Estimate revisions
  • Earnings Announcements
  • Zacks Rank changes

If you answered yes, then how are you staying on top of these changes for your stocks? If you are one of the 45,000 investors who wake up every morning to the Daily Portfolio Updates emails from Zacks.com, then you are all set. If not, then sign up now to get this vital information sent to you daily to help take definitive action to improve your portfolio's performance. Did we mention it's free? Get started now!


We hope you enjoyed this issue of "Profit from the Pros", And we look forward to visiting with you again next week.

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. If you're reading a forwarded copy, sign up for your own, so you get this wealth of information every week. Just click here. THANKS!

Regards and Happy Investing,

Charles Rotblut, CFA

Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? Click here to find out how we will help you become a more successful investor.


The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.

The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
155 N. Wacker Drive, 6th Floor
Chicago, IL 60606

To unsubscribe from receiving "Profit from the Pros" e-mail newsletter, click here.


 

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.